Lisata Therapeutics, Inc.
LSTA
$2.26
$0.17568.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 4.10% | 3.38% | 60.68% | 64.31% | 61.57% |
| Total Depreciation and Amortization | -7.94% | -4.76% | 23.33% | 70.00% | 173.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.85% | -18.66% | -97.69% | -97.06% | -96.80% |
| Change in Net Operating Assets | -88.96% | 128.14% | 108.46% | 104.56% | 44.40% |
| Cash from Operations | 3.37% | 15.75% | 12.62% | 20.49% | 5.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.99% | -73.29% | 51.44% | -71.44% | -68.93% |
| Cash from Investing | 30.99% | -73.26% | 90.91% | -68.82% | -65.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -85.71% | -87.98% | -87.98% | 1,006.98% | 1,006.98% |
| Repurchase of Common Stock | -201.10% | -56.04% | 19.57% | 19.57% | 65.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -153.51% | -122.93% | -132.62% | 332.62% | 271.88% |
| Foreign Exchange rate Adjustments | -243.75% | -178.57% | -20.00% | -276.47% | -60.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.23% | -1,459.89% | 147.66% | -141.21% | -227.36% |